Enhancing Dissolution and Bioavailability: A Review on Co-Processed Superdisintegrants in Pharmaceutical Formulations
Abstract
Co-processed superdisintegrants have emerged as key excipients in pharmaceutical formulation development, offering solutions to challenges related to poor solubility, bioavailability, and patient compliance. This comprehensive review article provides an in-depth analysis of the principles, mechanisms, manufacturing techniques, and applications of co-processed superdisintegrants in drug delivery systems. The review highlights the role of co-processed excipients in enhancing dissolution kinetics, improving formulation efficiency, and enabling innovative drug delivery platforms such as personalized medicine and combination therapies. Regulatory considerations, quality standards, and future directions for research and innovation in this field are also discussed. Through a synthesis of current literature and insights into emerging trends, this review aims to provide researchers, formulation scientists, and pharmaceutical professionals with a comprehensive understanding of the potential and challenges associated with co-processed superdisintegrants in pharmaceutical formulations. Ultimately, the integration of co-processed excipients into formulation development holds promise for advancing drug delivery technology, improving therapeutic outcomes, and addressing unmet medical needs in patient care.
Keywords: Co-processed superdisintegrants, Dissolution enhancement, Bioavailability, Pharmaceutical formulations, Drug delivery systems, Excipients, Formulation optimization, Manufacturing techniques, Regulatory considerations, Future directions
Downloads
References
Sheshala R, Kishan V, Udupi RH, Udupi G, Shastry C. Superdisintegrants: An Overview. International Journal of Pharmaceutical Sciences and Research. 2011;2(4): 657-672.
Thakkar H, Dave R. A Review on Co-Processed Excipients. International Journal of Pharmacy and Pharmaceutical Sciences. 2011;3(2):18-24.
Pawar H, Lal C, Bansal AK. Co-processed Excipients: An Innovative Technique in Solid Dosage Form Design. Indian Journal of Pharmaceutical Sciences. 2009;71(5): 481-487.
Javadzadeh Y, Siahi Shadbad MR, Mohammadi G, Nokhodchi A. The effect of various grade and ratio of microcrystalline cellulose on the properties of naproxen tablets prepared by wet granulation method. Powder Technology. 2007;178(1): 46-52.
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews. 2001;46(1-3):3-26. https://doi.org/10.1016/S0169-409X(96)00423-1
2. Van Norman GA. Limitations of Animal Studies for Predicting Toxicity in Clinical Trials: Is it Time to Rethink Our Current Approach?. Journal of the American College of Cardiology. 2019;73(14): 1917-1919.
Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research. 1995;12(3):413-420. https://doi.org/10.1023/A:1016212804288 PMid:7617530
Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. European Journal of Pharmaceutical Sciences. 2006;29(3-4):278-287. https://doi.org/10.1016/j.ejps.2006.04.016 PMid:16815001
Craig DQM. The mechanisms of drug release from solid dispersions in water-soluble polymers. International Journal of Pharmaceutics. 2002;231(2):131-144. https://doi.org/10.1016/S0378-5173(01)00891-2 PMid:11755266
Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system. European Journal of Pharmaceutical Sciences. 2004;20(5):441-451.
Singla AK, Chawla M. Chitosan: some pharmaceutical and biological aspects-an update. Journal of Pharmacy and Pharmacology. 2001;53(8):1047-1067. https://doi.org/10.1211/0022357011776441 PMid:11518015
Möschwitzer JP. Drug nanocrystals in the commercial pharmaceutical development process. International Journal of Pharmaceutics. 2013;453(1):142-156. https://doi.org/10.1016/j.ijpharm.2012.09.034 PMid:23000841
Williams HD, Trevaskis NL, Charman SA, Shanker RM, Charman WN, Pouton CW, Porter CJ. Strategies to address low drug solubility in discovery and development. Pharmacological Reviews. 2013;65(1):315-499. https://doi.org/10.1124/pr.112.005660 PMid:23383426
Desai S, Bolton S. A comparative evaluation of the disintegration effectiveness of three superdisintegrants in promoting rifampicin tablet disintegration. Pharmaceutical Development and Technology. 1997;2(1):71-79.
Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research. 1995;12(3):413-420. https://doi.org/10.1023/A:1016212804288 PMid:7617530
Sheshala R, Kishan V, Udupi RH, Udupi G, Shastry C. Superdisintegrants: An Overview. International Journal of Pharmaceutical Sciences and Research. 2011;2(4):657-672.
Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy. Lea & Febiger; 1970.
Al-Tabakha MM. Comparative disintegration studies on innovator and generic immediate release tablets containing clopidogrel bisulfate. Saudi Pharmaceutical Journal. 2010;18(3):151-157.
Szakonyi G, Zelkó R. Use of experimental design in the development of a co-processed excipient consisting of lactose and croscarmellose sodium. European Journal of Pharmaceutical Sciences. 2002;16(1-2):111-117.
Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. European Journal of Pharmaceutical Sciences. 2006;29(3-4):278-287. https://doi.org/10.1016/j.ejps.2006.04.016 PMid:16815001
Van den Mooter G, Samyn C, Kinget R. Oral solid dispersions of HIV protease inhibitors: production, characterization, and selection of suitable excipients. Journal of Pharmaceutical Sciences. 2001;90(9): 1955-1966.
Patil SS, Jadhav SL, Pawar AP. Evaluation of fast dissolving tablets of domperidone: effect of functionality of superdisintegrants. Indian Journal of Pharmaceutical Sciences. 2009;71(5):611-615.
Mohammed FA, Abdulrahman S, Ghassan Z, Fatima A. The effect of superdisintegrants and disintegrant concentration on the release of atenolol from matrix tablet formulations. International Journal of Research and Development in Pharmacy & Life Sciences. 2015;4(1):1440-1446.
Kulkarni AS, Khale CN, Pawar SP, Kore SB. Use of disintegrants in drug formulations. Research Journal of Pharmacy and Technology. 2008;1(4):400-403.
Elhensheri MY, Ghorab MK, Ahmed OAA. Preparation and evaluation of fast disintegrating tablets containing rofecoxib solid dispersions. AAPS PharmSciTech. 2007;8(2):Article 40.
Thakkar H, Dave R. A Review on Co-Processed Excipients. International Journal of Pharmacy and Pharmaceutical Sciences. 2011;3(2):18-24.
Sheshala R, Kishan V, Udupi RH, Udupi G, Shastry C. Superdisintegrants: An Overview. International Journal of Pharmaceutical Sciences and Research. 2011;2(4):657-672.
Pawar H, Lal C, Bansal AK. Co-processed Excipients: An Innovative Technique in Solid Dosage Form Design. Indian Journal of Pharmaceutical Sciences. 2009;71(5):481-487.
Thakkar H, Dave R. A Review on Co-Processed Excipients. International Journal of Pharmacy and Pharmaceutical Sciences. 2011;3(2):18-24.
Pawar H, Lal C, Bansal AK. Co-processed Excipients: An Innovative Technique in Solid Dosage Form Design. Indian Journal of Pharmaceutical Sciences. 2009;71(5):481-487.
Gupta V, Bansal AK. Interactions in Co-processed Excipients: A Review. Asian Journal of Pharmaceutical Sciences. 2012;7(1):1-13.
Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research. 1995;12(3):413-420. https://doi.org/10.1023/A:1016212804288 PMid:7617530
Javadzadeh Y, Siahi Shadbad MR, Mohammadi G, Nokhodchi A. The effect of various grade and ratio of microcrystalline cellulose on the properties of naproxen tablets prepared by wet granulation method. Powder Technology. 2007;178(1):46-52.
Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discovery Today. 2007;12(23-24):1068-1075. https://doi.org/10.1016/j.drudis.2007.09.005 PMid:18061887
Jivraj I, Martini LG, Thomson CM. An overview of the different excipients useful for the direct compression of tablets. Pharmaceutical Science & Technology Today. 2000;3(2):58-63. https://doi.org/10.1016/S1461-5347(99)00237-0 PMid:10664574
Sheth P, Sandhu H, Shah N, Kothari S. A Review on Co-processed Excipients. Journal of Drug Delivery and Therapeutics. 2012;2(5):30-38.
Thakkar H, Dave R. A Review on Co-Processed Excipients. International Journal of Pharmacy and Pharmaceutical Sciences. 2011;3(2):18-24.
Pawar H, Lal C, Bansal AK. Co-processed Excipients: An Innovative Technique in Solid Dosage Form Design. Indian Journal of Pharmaceutical Sciences. 2009;71(5):481-487.
Sheth P, Sandhu H, Shah N, Kothari S. A Review on Co-processed Excipients. Journal of Drug Delivery and Therapeutics. 2012;2(5):30-38.
Rahman Z, Zidan AS, Khan MA. Non-disintegrating blends of microcrystalline cellulose and a-bacterial cellulose for direct compression: binder addition. AAPS PharmSciTech. 2009;10(3):916-923.
Arora P, Mukherjee B. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. Journal of Pharmaceutical Sciences. 2002;91(10):2076-2089. https://doi.org/10.1002/jps.10200 PMid:12210054
Kazi M, Gattani S, Amalnerkar D. Polacrilin potassium-based sustained-release matrix tablets of tramadol hydrochloride. AAPS PharmSciTech. 2008;9(1):81-88.
Madgulkar A, Bhalekar M, Sheladiya D. Co-processing: A Technical Aspects of the Process. International Journal of Pharmaceutical Sciences Review and Research. 2013;23(1):92-100.
Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Poloniae Pharmaceutica. 2010;67(3):217-223.
Rajkumar N, Sankar V, Mishra D. Co-processed Excipients: A Review. Journal of Drug Delivery and Therapeutics. 2019;9(3):602-608.
Sheth P, Sandhu H, Shah N, Kothari S. A Review on Co-processed Excipients. Journal of Drug Delivery and Therapeutics. 2012;2(5):30-38.
Javadzadeh Y, Siahi Shadbad MR, Mohammadi G, Nokhodchi A. The effect of various grade and ratio of microcrystalline cellulose on the properties of naproxen tablets prepared by wet granulation method. Powder Technology. 2007;178(1):46-52.
Arora P, Mukherjee B. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. Journal of Pharmaceutical Sciences. 2002;91(10):2076-2089. https://doi.org/10.1002/jps.10200 PMid:12210054
Kazi M, Gattani S, Amalnerkar D. Polacrilin potassium-based sustained-release matrix tablets of tramadol hydrochloride. AAPS PharmSciTech. 2008;9(1):81-88.
Madgulkar A, Bhalekar M, Sheladiya D. Co-processing: A Technical Aspects of the Process. International Journal of Pharmaceutical Sciences Review and Research. 2013;23(1):92-100.
Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Poloniae Pharmaceutica. 2010;67(3):217-223.
Patel D, Patel M, Patel N, Prajapati B. Co-processed Excipients: An Approach to Better Patient Compliance and Cost-Effective Formulations. International Journal of Pharmaceutical Sciences and Research. 2013;4(11):4143-4154.
Shah T, Pandey S, Shah S, Patel J, Patel N. Co-processing: A Technique for Pharmaceutical Excipient Development. Journal of Drug Delivery and Therapeutics. 2019;9(2):375-380.
Pawar H, Lal C, Bansal AK. Co-processed Excipients: An Innovative Technique in Solid Dosage Form Design. Indian Journal of Pharmaceutical Sciences. 2009;71(5):481-487.
Madgulkar A, Bhalekar M, Sheladiya D. Co-processing: A Technical Aspects of the Process. International Journal of Pharmaceutical Sciences Review and Research. 2013;23(1):92-100.
Shah T, Pandey S, Shah S, Patel J, Patel N. Co-processing: A Technique for Pharmaceutical Excipient Development. Journal of Drug Delivery and Therapeutics. 2019;9(2):375-380.
Li X, Chen Y, Zhang D, Han X, Liu J, Liu Y. Recent advances in co-processed excipients: Preparation, characterization and application in drug delivery. International Journal of Pharmaceutics. 2020;586:119594.
Pawar H, Lal C, Bansal AK. Co-processed excipients: An emerging technique. Journal of Controlled Release. 2012;158(1):2-15.
Heng D, Lee S, Ng W, Tan R. Study of the different grades of microcrystalline cellulose on the properties of meloxicam granules prepared via melt granulation. Drug Development and Industrial Pharmacy. 2012;38(11):1334-1342.
Pawar H, Lal C, Bansal AK. Co-processed Excipients: An Innovative Technique in Solid Dosage Form Design. Indian Journal of Pharmaceutical Sciences. 2009;71(5):481-487.
Madgulkar A, Bhalekar M, Sheladiya D. Co-processing: A Technical Aspects of the Process. International Journal of Pharmaceutical Sciences Review and Research. 2013;23(1):92-100.
Shah T, Pandey S, Shah S, Patel J, Patel N. Co-processing: A Technique for Pharmaceutical Excipient Development. Journal of Drug Delivery and Therapeutics. 2019;9(2):375-380.
Rathore AS, Winkle H. Quality by Design for Biopharmaceuticals. John Wiley & Sons; 2015.
Gad SC. Pharmaceutical Manufacturing Handbook: Production and Processes. John Wiley & Sons; 2008. https://doi.org/10.1002/9780470259818
FDA. Guidance for Industry: Process Validation: General Principles and Practices. U.S. Department of Health and Human Services, Food and Drug Administration; 2011.
FDA. Guidance for Industry: Scale-Up and Post-Approval Changes (SUPAC) for Immediate Release Solid Oral Dosage Forms. U.S. Department of Health and Human Services, Food and Drug Administration; 1995.
Pawar H, Lal C, Bansal AK. Co-processed Excipients: An Innovative Technique in Solid Dosage Form Design. Indian Journal of Pharmaceutical Sciences. 2009;71(5):481-487.
Madgulkar A, Bhalekar M, Sheladiya D. Co-processing: A Technical Aspects of the Process. International Journal of Pharmaceutical Sciences Review and Research. 2013;23(1):92-100.
Shah T, Pandey S, Shah S, Patel J, Patel N. Co-processing: A Technique for Pharmaceutical Excipient Development. Journal of Drug Delivery and Therapeutics. 2019;9(2):375-380.
Mishra S, Shukla M, Yadav V, Mishra B. Co-Processed Excipients: A Review of Current Trends and Applications in Solid Dosage Forms. International Journal of Pharmaceutical Sciences and Research. 2021; 12(2): 721-730.
Kumar A, Patil M, Rajpoot K, Kumar P, Prakash O. Co-processed excipients: a novel approach for better pharmaceuticals. International Journal of Pharmacy and Pharmaceutical Sciences. 2011; 3(2): 48-54.
Hisham E, Hussain W, Saraiya R, et al. Co-Processed Excipients in Solid Dosage Form: A Review. International Journal of Pharmaceutical Sciences Review and Research. 2011; 8(1): 45-53.
Yinebeb T, Deyno S, Ahmed S, Ejigu Y. Co-Processed Excipients: A Review of Pharmaceutical Applications. Journal of Drug Delivery and Therapeutics. 2020; 10(4-s): 92-99.
Shang L, Wang H, Wang Q, Li F, Liu X. Current status and prospects of co-processed excipients in pharmaceutical tablets: a review. Pharmaceutical Development and Technology. 2020; 25(4): 419-432.
Dobetti L. Fast-melting tablets: Developments and technologies. Pharma Technology. 2001; 25(3): 52-58.
Srujana S, Anjamma M, Alimuddin, Singh B, Dhakar RC, Natarajan S, Hechhu R. A Comprehensive Study on the Synthesis and Characterization of TiO2 Nanoparticles Using Aloe vera Plant Extract and Their Photocatalytic Activity against MB Dye. Adsorption Science & Technology. 2022;2022 https://doi.org/10.1155/2022/7244006
Giri T, Paarakh P. Development and evaluation of novel co-processed superdisintegrants for fast disintegrating tablets of domperidone. Asian Journal of Pharmaceutics. 2018; 12(3): S650-S656.
Pabari R, Ramtoola Z. Co-processed excipients for solid dosage forms. Pharmaceutical Technology Europe. 2011; 23(2): 22-25.
Okoye N, Ogbonna J, Ogbonna C. Overview of co-processed excipients and their application in tablet dosage form. International Journal of Pharmaceutical Sciences Review and Research. 2013; 23(1): 315-321.
Parajapati S, Maurya S, Das M, Tilak VK, Verma KK, Dhakar RC. Potential Application of Dendrimers in Drug Delivery: A Concise Review and Update. Journal of Drug Delivery and Therapeutics. 2016;6(2):71-88 https://doi.org/10.22270/jddt.v6i2.1195
Pandey P, Garg R. Co-processed superdisintegrants: A novel excipient for pharmaceuticals formulation development. World Journal of Pharmacy and Pharmaceutical Sciences. 2017; 6(7): 495-509.
Mishra S, Shukla M, Yadav V, Mishra B. Co-Processed Excipients: A Review of Current Trends and Applications in Solid Dosage Forms. International Journal of Pharmaceutical Sciences and Research. 2021; 12(2): 721-730.
Maurya SD, Prajapati S, Gupta A, Saxena G, Dhakar RC, Formulation Development and Evaluation of Ethosome of Stavudine, Indian J.Pharm. Educ. Res. 2010;44(1)
Tiwari S, Pathak V. Co-processed excipients: A breakthrough in solid dosage form development. Journal of Drug Delivery and Therapeutics. 2019; 9(4): 657-663. https://doi.org/10.22270/jddt.v9i4-s.3351
Kumar A, Patil M, Rajpoot K, Kumar P, Prakash O. Co-processed excipients: A novel approach for better pharmaceuticals. International Journal of Pharmacy and Pharmaceutical Sciences. 2011; 3(2): 48-54.
Pathak P, Garg S, Sharma V. Co-processed excipients: A novel approach in drug delivery. Journal of Drug Delivery and Therapeutics. 2019; 9(2): 251-256.
Gupta D, Kumar A, Goyal AK, Rath G. Recent advances in co-processed excipients: A novel technique for modified drug delivery system. Artif Cells Nanomed Biotechnol. 2016; 44(1): 63-70.
Jyothi NV, Srinivas R, Chandrashekhar KB. Co-processing - A novel technique for improving excipients in pharmaceutical industry. Journal of Global Trends in Pharmaceutical Sciences. 2014; 5(3): 2047-2059.
Ghosh A, Sen KK. Multifunctional co-processed excipients: A review. International Journal of Pharmaceutical Sciences Review and Research. 2011; 7(1): 10-15.
Kumar S, Goyal AK, Mishra N, Vaidya B, Mehta A. Multifunctional excipients in pharmaceutical dosage forms: A review. Asian Journal of Pharmaceutical Sciences. 2016; 11(6): 675-683.
Dwivedi M, Chaudhary A, Pathak K. Natural excipients: A boon for pharmaceutical formulation. International Journal of Pharmacy and Pharmaceutical Sciences. 2017; 9(9): 1-8.
Javia A, Garg S, Jasrai Y. A review on natural excipients in pharmaceutical formulations. World Journal of Pharmacy and Pharmaceutical Sciences. 2015; 4(12): 1026-1039.
Rathore AS, Winkle H. Quality by design for biopharmaceuticals. Nature Biotechnology. 2009; 27(1): 26-34. https://doi.org/10.1038/nbt0109-26 PMid:19131992
Yu LX. Pharmaceutical quality by design: Product and process development, understanding, and control. Pharmaceutical Research. 2008; 25(4): 781-791. https://doi.org/10.1007/s11095-007-9511-1 PMid:18185986
Jain A, Gupta Y, Jain SK. Perspectives of co-processed excipients in development of solid dosage forms. International Journal of Drug Development and Research. 2011; 3(4): 29-36.
Shinde UA, Pokharkar VB, Chivate ND. Co-processed excipients: A novel technique for improving excipient performance. World Journal of Pharmacy and Pharmaceutical Sciences. 2014; 3(4): 1611-1628.
ICH Harmonised Tripartite Guideline. Pharmaceutical Development Q8(R2). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2009.
Thakur D, Nanda A, Sharma R. Co-processed excipients: A review on novel excipient for novel drugs. International Journal of Research in Pharmacy and Chemistry. 2011; 1(4): 964-972.
Garg A, Aggarwal D, Garg S, Singla AK. Co-processed excipients: A review. International Journal of Pharmaceutical Sciences Review and Research. 2010; 5(1): 72-78.
Akhgari A, Zakeri-Milani P, Valizadeh H, Yousefi H, Shahbazi Mojarrad J, Gheshlaghi Z. Co-processing as a method to improve drug delivery systems: a case study of superdisintegrants. Pharmaceutical Development and Technology. 2016; 21(5): 567-576.
US Food and Drug Administration. Guidance for Industry: Nonclinical Studies for the Safety Evaluation of Pharmaceutical Excipients. 2017.
European Medicines Agency. Guideline on Excipients in the Dossier for Application for Marketing Authorisation of a Medicinal Product. 2007.
Rowe RC, Sheskey PJ, Quinn ME, editors. Handbook of Pharmaceutical Excipients. 7th ed. London: Pharmaceutical Press; 2012.
US Pharmacopeia-National Formulary. USP 43-NF 38. Rockville, MD: US Pharmacopeial Convention; 2020
Copyright (c) 2024 Shubham Sachdeva, Harpreet Singh, Jitender Singh
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
. 